Eli Lilly Becomes First Drugmaker to Reach $1 Trillion Valuation
Eli Lilly (LLY.N) hit a historic milestone on Friday, becoming the first pharmaceutical company to reach a $1 trillion market valuation, fueled by soaring demand for its weight-loss treatments. The achievement places Lilly in the rarefied ranks of U.S. companies with trillion-dollar valuations, a group historically dominated by tech giants like Apple, Microsoft, and Amazon. Read More…